ticlopidine has been researched along with thromboxanes in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (21.43) | 18.7374 |
| 1990's | 5 (35.71) | 18.2507 |
| 2000's | 4 (28.57) | 29.6817 |
| 2010's | 2 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Karasawa, A; Kubo, K; Shirakura, S | 1 |
| Ishii, A; Karasawa, A; Kawakage, M; Kubo, K; Miki, I; Shirakura, S; Takeda, M | 1 |
| Cerbone, AM; Di Minno, G; Iride, C; Mancini, M; Mattioli, PL; Postiglione, A | 1 |
| Gragnoli, G; Signorini, AM; Tanganelli, I | 1 |
| d'Avenia, V; di Minno, G; Iovine, C; Mattioli, PL; Turco, S | 1 |
| Imura, Y; Kato, K; Kawamura, M; Nishikawa, K; Terashita, Z | 1 |
| Higo, K; Karasawa, A; Shirakura, S; Takeda, M | 1 |
| Boissonnat, P; Bordet, JC; de Lorgeril, M; Defreyn, G; Delaye, J; Durbin, S; Salen, P | 1 |
| Lecompte, T | 1 |
| Bhatt, DL; Meadows, TA | 1 |
| Lanas, A; Nardulli, G | 1 |
| Lindhoff-Last, E; Mani, H | 1 |
| Bhavaraju, K; Gartner, TK; Georgakis, A; Jin, J; Kunapuli, SP; Nurden, A; Nurden, P; Tomiyama, Y | 1 |
| Sas, K; Sztriha, LK; Vadász, D; Vécsei, L | 1 |
5 review(s) available for ticlopidine and thromboxanes
| Article | Year |
|---|---|
[Platelet inhibitors: old and new].
Topics: Abciximab; Antibodies, Monoclonal; Arteriosclerosis; Aspirin; Clopidogrel; Coronary Disease; Dipyridamole; Drug Monitoring; Eptifibatide; Humans; Immunoglobulin Fab Fragments; Membrane Proteins; Patient Selection; Peptides; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Receptors, Purinergic P2; Receptors, Purinergic P2Y12; Thrombosis; Thromboxanes; Ticlopidine | 2002 |
Clinical aspects of platelet inhibitors and thrombus formation.
Topics: Aspirin; Atherosclerosis; Blood Platelets; Cardiovascular Diseases; Cilostazol; Clopidogrel; Dipyridamole; Drug Resistance; Humans; Pentanoic Acids; Platelet Adhesiveness; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Purinergic P2 Receptor Antagonists; Pyridines; Receptor, PAR-1; Stents; Tetrazoles; Thrombosis; Thromboxanes; Ticlopidine | 2007 |
[Risk of gastrointestinal bleeding with aspirin and platelet antiaggregants].
Topics: Age Factors; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Clopidogrel; Cyclooxygenase 1; Cyclooxygenase Inhibitors; Dinoprostone; Gastrointestinal Hemorrhage; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Middle Aged; Misoprostol; Peptic Ulcer Hemorrhage; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Risk Factors; Thromboxanes; Ticlopidine | 2009 |
[Diagnosis, causes, relevance of a complex phenomenon. Resistance to aspirin and clopidogrel].
Topics: Aspirin; Blood Platelets; Clopidogrel; Drug Interactions; Drug Resistance; Humans; Phosphorylation; Platelet Aggregation Inhibitors; Platelet Function Tests; Thrombosis; Thromboxanes; Ticlopidine | 2009 |
Aspirin and clopidogrel resistance: possible mechanisms and clinical relevance. Part II: Potential causes and laboratory tests.
Topics: Age Factors; Aspirin; Biological Availability; Clopidogrel; Drug Administration Schedule; Drug Interactions; Drug Resistance; Humans; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Function Tests; Polymorphism, Genetic; Sex Factors; Signal Transduction; Thromboxanes; Ticlopidine | 2013 |
2 trial(s) available for ticlopidine and thromboxanes
| Article | Year |
|---|---|
Ticlopidine increases nitric oxide generation in heart-transplant recipients: a possible novel property of ticlopidine.
Topics: Analysis of Variance; Blood Platelets; Double-Blind Method; Endothelium, Vascular; Epoprostenol; Heart Transplantation; Humans; Immunosuppression Therapy; Male; Nitric Oxide; Platelet Aggregation Inhibitors; Thromboxanes; Ticlopidine | 1998 |
Antagonism of P2Y₁₂ reduces physiological thromboxane levels.
Topics: Adenosine Diphosphate; Adolescent; Adult; Animals; Blood Platelets; Clopidogrel; Female; Humans; Male; Mice; Mice, Knockout; Middle Aged; Pilot Projects; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; Receptors, Purinergic P2Y12; Thiophenes; Thromboxanes; Ticlopidine; Young Adult | 2010 |
7 other study(ies) available for ticlopidine and thromboxanes
| Article | Year |
|---|---|
Protective effects of the novel thromboxane A2 receptor antagonist sodium (E)-11-[2-(5,6-dimethyl-1-benzimidazolyl)-ethylidene]-6,11- dihydrodibenz[b,e]oxepine-2-carboxylate monohydrate against 9,11-dideoxy- 9 alpha, 11 alpha-epoxymethano-prostaglandin F2
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Aspirin; Benzimidazoles; Benzoxepins; Blood Pressure; Death, Sudden; Dose-Response Relationship, Drug; Guinea Pigs; Male; Phenylacetates; Platelet Aggregation Inhibitors; Platelet Count; Prostaglandin Endoperoxides, Synthetic; Rats; Rats, Inbred Strains; Sulfonamides; Thromboxane A2; Thromboxanes; Ticlopidine | 1991 |
Beneficial effect of the novel thromboxane A2 receptor antagonist sodium (E)-11-[2-(5,6-dimethyl-1-benzimidazolyl)ethylidene]-6,11- dihydrodibenz[b,e]oxepine-2-carboxylate monohydrate on collagen-induced coronary ischemia in guinea-pigs.
Topics: Animals; Arrhythmias, Cardiac; Benzimidazoles; Benzoxepins; Collagen; Coronary Disease; Cyclooxygenase Inhibitors; Electrocardiography; Guinea Pigs; Heart Arrest; Male; Nifedipine; Phenylacetates; Propranolol; Sulfonamides; Thromboxane A2; Thromboxane B2; Thromboxanes; Ticlopidine | 1991 |
Platelet fibrinogen binding in familial hypercholesterolemia.
Topics: Adenosine Diphosphate; Adolescent; Adult; Blood Platelets; Child; Female; Fibrinogen; Humans; Hyperlipoproteinemia Type II; Male; Platelet Aggregation; Platelet Membrane Glycoproteins; Protein Binding; Thromboxanes; Ticlopidine | 1987 |
[Effects of ticlopidine on the plasma levels of beta-thromboglobulin and thromboxane B2 in types 1 and 2 diabetics].
Topics: Beta-Globulins; beta-Thromboglobulin; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Humans; Thiophenes; Thromboxane B2; Thromboxanes; Ticlopidine | 1984 |
Ex vivo effects of ticlopidine on human platelets: inhibition of fibrinogen binding by a mechanism independent of thromboxane formation.
Topics: Anticoagulants; Blood Platelets; Fibrinogen; Humans; Platelet Aggregation; Thiophenes; Thromboxanes; Ticlopidine | 1984 |
Effects of thromboxane A2 synthase inhibitors (CV-4151 and ozagrel), aspirin, and ticlopidine on the thrombosis caused by endothelial cell injury.
Topics: Animals; Aspirin; Bleeding Time; Endothelium, Vascular; Fatty Acids, Monounsaturated; Femoral Vein; Male; Methacrylates; Platelet Aggregation; Pyridines; Rats; Rats, Sprague-Dawley; Thrombosis; Thromboxane-A Synthase; Thromboxanes; Ticlopidine | 1995 |
Antithrombotic effects of KW-3635, a thromboxane A2-receptor antagonist, in guinea pigs.
Topics: Animals; Arterial Occlusive Diseases; Aspirin; Benzimidazoles; Benzoxepins; Blood Coagulation; Blood Platelets; Disease Models, Animal; Erythrocyte Count; Femoral Artery; Guinea Pigs; Lauric Acids; Male; Phenylacetates; Platelet Count; Sulfonamides; Thrombosis; Thromboxane A2; Thromboxanes; Ticlopidine | 1994 |